Establishes the Prescription Drug Cost and Affordability Review Act to create a board and council to review prescription drug costs and affordability.
The Prescription Drug Cost and Affordability Review Act establishes a Prescription Drug Affordability Board and a Prescription Drug Affordability Stakeholder Council within the Department of Insurance and Financial Services. The Board reviews prescription drug costs and affordability, considering factors like wholesale acquisition costs, market competition, and patient access. The Council assists the Board and includes representatives from various healthcare sectors. The Board can establish upper payment limits for certain drugs and must submit annual reports to the legislature.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.